222 related articles for article (PubMed ID: 7908057)
21. Cardiac effects of beta-2 adrenoceptor stimulation with intracoronary procaterol in the absence and presence of regional myocardial ischemia in dogs.
Noguchi K; Ojiri Y; Chibana T; Moromizato H; Sakanashi M
J Pharmacol Exp Ther; 1991 Nov; 259(2):732-7. PubMed ID: 1682484
[TBL] [Abstract][Full Text] [Related]
22. Pharmacological characterization of a beta 3-receptor agonist (BRL 37,344) and a partial agonist (CGP 12,177A) in neonatal rat liver plasma membranes.
Fraeyman N; Van Ermen A; Van de Velde E; Vanscheeuwijck P
Biochem Pharmacol; 1992 Dec; 44(12):2333-8. PubMed ID: 1361733
[TBL] [Abstract][Full Text] [Related]
23. beta(1)- and beta(3)-adrenoceptor mediated smooth muscle relaxation in hypothyroid rat ileum.
Brown KJ; Summers RJ
Eur J Pharmacol; 2001 Mar; 415(2-3):257-63. PubMed ID: 11275008
[TBL] [Abstract][Full Text] [Related]
24. In vitro and in vivo pharmacological characterization of ethyl-4-[trans-4-[((2S)-2-hydroxy-3-[4-hydroxy-3[(methylsulfonyl)amino]-phenoxy]propyl) amino]cyclohexyl]benzoate hydrochloride (SAR150640), a new potent and selective human beta3-adrenoceptor agonist for the treatment of preterm labor.
Croci T; Cecchi R; Marini P; Rouget C; Viviani N; Germain G; Guagnini F; Fradin Y; Descamps L; Pascal M; Advenier C; Breuiller-Fouché M; Leroy MJ; Bardou M
J Pharmacol Exp Ther; 2007 Jun; 321(3):1118-26. PubMed ID: 17351104
[TBL] [Abstract][Full Text] [Related]
25. Positive chronotropic and inotropic responses to BRL 37344, a beta 3-adrenoceptor agonist in isolated, blood-perfused dog atria.
Takayama S; Furukawa Y; Ren LM; Inoue Y; Sawaki S; Chiba S
Eur J Pharmacol; 1993 Feb; 231(3):315-21. PubMed ID: 8095462
[TBL] [Abstract][Full Text] [Related]
26. Inhibitory effect of beta3-adrenoceptor agonist in lower esophageal sphincter smooth muscle: in vitro studies.
Sarma DN; Banwait K; Basak A; DiMarino AJ; Rattan S
J Pharmacol Exp Ther; 2003 Jan; 304(1):48-55. PubMed ID: 12490574
[TBL] [Abstract][Full Text] [Related]
27. [Relaxation of canine pulmonary arteries caused by stimulation of atypical beta-adrenergic receptors].
Tagaya E; Tamaoki J; Takemura H; Isono K; Nagai A
Nihon Kokyuki Gakkai Zasshi; 1998 May; 36(5):433-7. PubMed ID: 9742859
[TBL] [Abstract][Full Text] [Related]
28. Role of the beta(3)-adrenoceptor in urine storage in the rat: comparison between the selective beta(3)-adrenoceptor agonist, CL316, 243, and various smooth muscle relaxants.
Takeda H; Yamazaki Y; Akahane M; Igawa Y; Ajisawa Y; Nishizawa O
J Pharmacol Exp Ther; 2000 Jun; 293(3):939-45. PubMed ID: 10869395
[TBL] [Abstract][Full Text] [Related]
29. Peripheral cardiovascular actions of SR 58611 A, a beta 3-adrenoceptor agonist, in the dog: lack of central effect.
Montastruc JL; Verwaerde P; Pelat M; Galitzky J; Langin D; Lafontan M; Berlan M
Fundam Clin Pharmacol; 1999; 13(2):180-6. PubMed ID: 10226761
[TBL] [Abstract][Full Text] [Related]
30. The effects of bufuralol, a beta-adrenoceptor antagonist with predominant beta 2-adrenoceptor agonistic activity, in the cat and the dog.
Blaber LC; Burden DT; Eigenmann R; Gerold M
J Cardiovasc Pharmacol; 1984; 6(1):165-75. PubMed ID: 6199600
[TBL] [Abstract][Full Text] [Related]
31. Comparison between CL-316243- and CGP-12177A-induced relaxations in isolated canine ureter.
Tomiyama Y; Murakami M; Yamazaki Y; Kojima M; Akahane M
Pharmacology; 2003 Jul; 68(3):140-6. PubMed ID: 12784085
[TBL] [Abstract][Full Text] [Related]
32. Effect of cooling on cutaneous microvascular adrenoceptors in vivo in the rabbit ear.
Li Z; Koman LA; Rosencrance E; Pollock DC; Smith BP; Strandhoy JW; Smith TL
J Orthop Res; 1998 Mar; 16(2):190-6. PubMed ID: 9621893
[TBL] [Abstract][Full Text] [Related]
33. Relaxations to beta-adrenoceptor subtype selective agonists in wild-type and NOS-3-KO mouse mesenteric arteries.
Al Zubair K; Bexis S; Docherty JR
Eur J Pharmacol; 2008 Jun; 587(1-3):216-23. PubMed ID: 18455721
[TBL] [Abstract][Full Text] [Related]
34. Desensitization of beta-1 and beta-2, but not beta-3, adrenoceptor-mediated lipolytic responses of adipocytes after long-term norepinephrine infusion.
Carpéné C; Galitzky J; Collon P; Esclapez F; Dauzats M; Lafontan M
J Pharmacol Exp Ther; 1993 Apr; 265(1):237-47. PubMed ID: 8097243
[TBL] [Abstract][Full Text] [Related]
35. Beta3-adrenoceptors mediate relaxation of guinea pig taenia caecum by BRL37344A and BRL35135A.
Koike K; Takayanagi I; Ichino T; Koshikawa H; Nagatomo T
Eur J Pharmacol; 1997 Sep; 334(2-3):217-21. PubMed ID: 9369351
[TBL] [Abstract][Full Text] [Related]
36. Beta 2-adrenoceptors mediate a reduction in endothelial permeability in vitro.
Allen MJ; Coleman RA
Eur J Pharmacol; 1995 Feb; 274(1-3):7-15. PubMed ID: 7768283
[TBL] [Abstract][Full Text] [Related]
37. Agonist-induced desensitization of beta-adrenoceptor function in humans. Subtype-selective reduction in beta 1- or beta 2-adrenoceptor-mediated physiological effects by xamoterol or procaterol.
Brodde OE; Daul A; Michel-Reher M; Boomsma F; Man in 't Veld AJ; Schlieper P; Michel MC
Circulation; 1990 Mar; 81(3):914-21. PubMed ID: 1968366
[TBL] [Abstract][Full Text] [Related]
38. Analysis of beta-adrenoceptors mediating renin release produced by isoproterenol in conscious dogs.
Himori N; Izumi A; Ishimori T
Am J Physiol; 1980 May; 238(5):F387-93. PubMed ID: 6103674
[TBL] [Abstract][Full Text] [Related]
39. Activation of beta2- and beta3-adrenergic receptors increases brain tryptophan.
Lenard NR; Gettys TW; Dunn AJ
J Pharmacol Exp Ther; 2003 May; 305(2):653-9. PubMed ID: 12606631
[TBL] [Abstract][Full Text] [Related]
40. Peripheral vascular effects of beta-3 adrenergic receptor stimulation in conscious dogs.
Shen YT; Zhang H; Vatner SF
J Pharmacol Exp Ther; 1994 Jan; 268(1):466-73. PubMed ID: 7905532
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
